Objective: Dementia with Lewy bodies (DLB) is a common cause of dementia, but atrophy is mild compared to Alzheimer's disease. We propose that DLB is associated instead with severe synaptic loss, and we test this hypothesis in vivo using positron emission tomography (PET) imaging of C-UCB-J, a ligand for presynaptic vesicle protein 2A (SV2A), a vesicle membrane protein ubiquitously expressed in synapses.

Methods: We performed C-UCB-J PET in two DLB patients (an amyloid-negative male and an amyloid-positive female in their 70s) and 10 similarly aged healthy controls. The DLB subjects also underwent PET imaging of amyloid (C-PiB) and tau (F-AV-1451). C-UCB-J binding was quantified using non-displaceable binding potential (BP) determined from dynamic imaging. Changes in C-UCB-J binding were correlated with MRI regional brain volume, C-PiB uptake and F-AV-1451 binding.

Results: Compared to controls, both patients had decreased C-UCB-J binding, especially in parietal and occipital regions (FDR-corrected < 0.05). There were no significant correlations across regions between C-UCB-J binding and grey matter, tau (F-AV1451) or amyloid (C-PiB) in either patient.

Conclusions: Quantitative imaging of in vivo synaptic density in DLB is a promising approach to understanding the mechanisms of DLB, over and above changes in grey matter volume and concurrent amyloid/tau deposition.

Supplementary Information: The online version contains supplementary material available at 10.1186/s41824-020-00093-9.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752786PMC
http://dx.doi.org/10.1186/s41824-020-00093-9DOI Listing

Publication Analysis

Top Keywords

c-ucb-j binding
16
dementia lewy
8
lewy bodies
8
pet imaging
8
amyloid c-pib
8
grey matter
8
c-ucb-j
7
dlb
6
imaging
5
binding
5

Similar Publications

Synaptic vesicle protein 2A (SV2A) is ubiquitously expressed in presynaptic terminals where it functions as a neurotransmission regulator protein. Synaptopathy has been reported during healthy ageing and in a variety of neurodegenerative diseases. Positron emission tomography (PET) imaging of SV2A can be used to evaluate synaptic density.

View Article and Find Full Text PDF

Vagus nerve stimulation (VNS) is the subject of exploration as an adjunct treatment for neurological disorders such as epilepsy, chronic migraine, pain, and depression. A non-invasive form of VNS is transcutaneous auricular VNS (taVNS). Combining animal models and positron emission tomography (PET) may lead to a better understanding of the elusive mechanisms of taVNS.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the relationship between metabotropic glutamate receptor subtype 5 (mGluR5) and synaptic density in early Alzheimer's disease (AD) using PET imaging techniques.
  • Findings reveal a strong positive correlation between mGluR5 levels and synaptic density in the hippocampus and entorhinal cortex of Alzheimer’s patients, but less significant in cognitively normal individuals.
  • The research concludes that loss of mGluR5 in the medial temporal lobe is linked to synaptic loss, suggesting its potential role in AD pathology.
View Article and Find Full Text PDF
Article Synopsis
  • The study investigates synaptic density in autistic adults using positron emission tomography (PET) and synaptic vesicle glycoprotein 2A (SV2A) as a marker.
  • Results show that autistic individuals exhibit a 17% lower synaptic density across the whole cortex compared to non-autistic peers, with significant deficits in various brain regions, especially the prefrontal cortex.
  • The findings suggest that lower synaptic density is associated with increased autistic features, pointing to a potential molecular basis for autism that requires further exploration.
View Article and Find Full Text PDF

Noninvasive quantification of [F]SynVesT-1 binding using simplified reference tissue model 2.

Eur J Nucl Med Mol Imaging

December 2024

Department of Radiology and Biomedical Imaging, Yale School of Medicine, 801 Howard Avenue, PO Box 208048, New Haven, CT, 06520- 8048, USA.

Purpose: [F]SynVesT-1, a positron emission tomography (PET) radiotracer for the synaptic vesicle glycoprotein 2A (SV2A), demonstrates kinetics similar to [C]UCB-J, with high brain uptake, fast kinetics fitting well with the one-tissue compartment (1TC) model, and excellent test-retest reproducibility. Challenges arise due to the similarity between k and [Formula: see text] (efflux rate of the reference region), when applying the simplified reference tissue model (SRTM) and related methods in [C]UCB-J studies to accurately estimate [Formula: see text]. This study evaluated the suitability of these methods to estimate [F]SynVesT-1 binding using centrum semiovale (CS) or cerebellum (CER) as reference regions.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!